<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Aurora A "over-"expression may induce supernumerary centrosomes, respective multipolar mitoses, and <z:mp ids='MP_0004024'>aneuploidy</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we examined Aurora A positive multipolar mitoses in aneuploid, microsatellite-stable (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>, "CIN-type") versus near-diploid, microsatellite-instable (MSI, "MIN-type") colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines as well as the effect of Aurora A inhibition in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines </plain></SENT>
<SENT sid="2" pm="."><plain>In situ, three-dimensional immunofluorescence (3D-IF) revealed Aurora A positive multipolar mitoses in both CIN- (n = 8) and MIN- (n = 10) type primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> with similar frequencies (CIN: 27 ± 14%; MIN: 34 ± 14%, P = 0.224) </plain></SENT>
<SENT sid="3" pm="."><plain>In vitro, Aurora A positive multipolar mitoses were detected in asynchronized or <z:chebi fb="0" ids="17748">thymidine</z:chebi> synchronized CIN-type (HT29, CaCo-2), but not MIN-type (HCT116, DLD-1) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="34892">Nocodazole</z:chebi> treatment arrested mitotic cells with multiple centrosomal Aurora A signals in CIN- and MIN-type <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells, albeit to a lower extent in CaCo-2 cells </plain></SENT>
<SENT sid="5" pm="."><plain>This was associated with concomitant activation of Aurora A (T288 phosphorylation) and Polo-like kinase 1 (PLK-1, T210 phosphorylation) </plain></SENT>
<SENT sid="6" pm="."><plain>Aurora A inhibition by siRNA resulted in <z:mp ids='MP_0006042'>increased apoptosis</z:mp> (&gt;50%) in <z:hpo ids='HP_0000001'>all</z:hpo> cell lines, but did not abolish PLK-1 expression </plain></SENT>
<SENT sid="7" pm="."><plain>Double 3D-IF revealed that Aurora A siRNA treated, still viable CIN-type (HT29, CaCo-2) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells were Aurora A negative and mostly in prophase/(pro)metaphase with maintained phosphorylated PLK-1 T210 expression </plain></SENT>
<SENT sid="8" pm="."><plain>Aurora A positive multipolar mitoses occur in both aneuploid, CIN- and near-diploid MIN-type <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>This appears to be largely independent of Aurora A expression alone </plain></SENT>
<SENT sid="10" pm="."><plain>Although Aurora A inhibition causes <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in both CIN- and MIN-type <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells, remaining PLK-1 activation by other factors may affect therapeutic Aurora inhibition </plain></SENT>
</text></document>